Verve Therapeutics, Inc. (VERV) is a biotechnology company that focuses on developing innovative therapies for cardiovascular diseases. As an investor, it is important to understand the technical analysis of VERV stock to make informed decisions. Technical indicators can provide valuable insights into the price movements and trends of the stock.

One commonly used technical indicator is the Relative Strength Index (RSI), which measures the strength and momentum of the stock. A high RSI value suggests that the stock is overbought, while a low RSI value indicates that it is oversold. Monitoring the RSI of VERV stock can help identify potential buying or selling opportunities.

Verve Therapeutics (VERV) Technical Analysis

Technical indicators including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR for Verve Therapeutics, Inc. (VERV) stock. Get insights into the stock's performance and trends. Find opportunities for investment analysis and decision-making.

Verve Therapeutics, Inc. (VERV) Technical Analysis - RSI, ADX, MACD, ROC, STOCHRSI, WILLR

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Verve Therapeutics

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	41.27	Neutral	42.9%
auto_graphMACD	-0.43	Neutral	101.6%
auto_graphCCI	-57.84	Neutral	81.4%
auto_graphADX	18.12	Neutral	0.4%
auto_graphATR	2.50	Buy	-
auto_graphWILLR	-92.29	Buy	-99.9%
auto_graphROC	-8.74	Sell	60.2%
auto_graphSTOCHRSI	0.00	Buy	30.6%

Buy	3	-62.50%
Hold	4	-50.00%
Sell	1	-87.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Verve Therapeutics (VERV) Technical Analysis

Keep an eye on Verve Therapeutics

Frequently Asked Questions

What are the technical signals for Verve Therapeutics (VERV) stock based on the last 30 days?

Take Your Investments to a Whole New Level